@jacobzemer's TRT supervision claims, fact-checked

What did @jacobzemer actually say?

Zemer draws two lines between TRT and "just taking steroids": medical supervision and staying within physiological testosterone levels. He says he sees his doctor four times a year, gets regular labs, and maintains testosterone between "700 to 900 nanograms" per deciliter. To illustrate supraphysiological use, he cites Dallas Carver, a bodybuilder who died at 26 with allegedly 52,000 ng/dL of testosterone.

He's upfront that he's not a doctor and frames this as personal opinion. That disclaimer matters. But 77,000 views means a lot of people are treating this as a reference point for understanding TRT, so the details deserve scrutiny.

Does the science back this up?

Mostly, yes, with some caveats. The two-distinction framework is a reasonable lay explanation, and the testosterone reference range he cites is broadly correct. The normal adult male range of 300 to 1,000 ng/dL aligns with guidelines from the American Urological Association and the Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).

Medical supervision genuinely does change the risk profile of testosterone therapy. Regular monitoring of hematocrit, PSA, lipid panels, and estradiol is standard of care, and there's real evidence that unmonitored testosterone use carries higher cardiovascular and hematological risk (Lincoff et al., 2023, New England Journal of Medicine). His point about being "empowered" through knowing his labs isn't just motivational fluff. Patients who engage actively with their health data tend to have better treatment adherence and outcomes.

The Dallas Carver figure of 52,000 ng/dL is unverifiable from publicly available autopsy records. The claim circulates in bodybuilding communities, but no peer-reviewed source confirms it.

What did they get wrong (or right)?

He got the fundamentals right. The distinction between physiological replacement and supraphysiological dosing is real and clinically meaningful. Testosterone at 700 to 900 ng/dL sits within the normal adult range. Anabolic steroid protocols used in competitive bodybuilding routinely push levels many multiples higher, with correspondingly greater risks to the heart, liver, and endocrine system.

Where he goes wrong: supervision alone does not make TRT risk-free. Even within normal testosterone ranges, TRT raises hematocrit in a meaningful percentage of patients, increases cardiovascular event risk in certain populations, and can suppress natural testosterone production permanently (Ramasamy et al., 2015, Journal of Urology). The TRAVERSE trial (Lincoff et al., 2023) found TRT was non-inferior to placebo for major cardiovascular events, but also found higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group. That's not a reason to avoid TRT if you need it. It is a reason not to present medical supervision as a near-complete safety guarantee.

The Dallas Carver statistic also needs to be flagged. Using an unverified figure to illustrate a point about supraphysiological levels is sloppy, even if the broader point is directionally correct.

What should you actually know?

The core message here is defensible: TRT managed by a physician with regular labs is a different category from unsupervised anabolic steroid use. That distinction is real, and Zemer is reasonable to make it.

But "medically supervised" is not a blanket safety certification. The Endocrine Society guidelines (Bhasin et al., 2018) recommend TRT only for men with confirmed hypogonadism, defined as consistently low testosterone plus symptoms, not just a preference for higher energy or libido. The phrase "optimal physiological level" is doing a lot of work in this video. For men with clinically confirmed low testosterone, 700 to 900 ng/dL may be appropriate. For men without hypogonadism, targeting the upper end of the normal range through exogenous testosterone is a different conversation, and not one this video has.

If you're considering TRT, the questions to bring to a real doctor include: Do I have confirmed hypogonadism? What is my cardiovascular baseline? What are the fertility implications? What does long-term monitoring look like? A four-times-a-year lab cadence is a reasonable minimum, but it does not eliminate risk. It manages it.

FormBlends verdict

Zemer is transparent about his non-medical status, credits his physician repeatedly, and stays within a framework that is broadly consistent with clinical guidelines. The two distinctions he draws are legitimate. The Dallas Carver figure is unverified and should be treated skeptically. The framing of medical supervision as delivering near-total confidence in health outcomes overstates what the evidence actually shows. Give this a "mostly accurate" with a flag on the risk minimization.